Information:
Fel:
ID
28389
Beskrivning
Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia; Eligibility ODM derived from: https://clinicaltrials.gov/show/NCT00512083
Länk
https://clinicaltrials.gov/show/NCT00512083
Nyckelord
Versioner (2)
- 2018-01-10 2018-01-10 - Julian Varghese
- 2018-01-10 2018-01-10 - Stefan Hegselmann
Rättsinnehavare
Mueller
Uppladdad den
10 januari 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Leukemia, Myeloid NCT00512083
Eligibility Leukemia, Myeloid NCT00512083
- StudyEvent: Eligibility
Similar models
Eligibility Leukemia, Myeloid NCT00512083
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
primary refractory or relapsed aml
boolean
C0278780 (UMLS CUI [1])
ID.2
Item
confirmed diagnosis of aml (de novo or secondary) as defined by who classification (vardiman 2002)
boolean
C0023467 (UMLS CUI [1,1])
C0011900 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,2])
ID.3
Item
aged at least 18 years
boolean
C0001779 (UMLS CUI [1])
ECOG performance
Item
Does the subject have an Eastem Cooperative Oncology Group (ECOG) Performance Status (PS) greater than 2?
boolean
C1520224 (UMLS CUI [1])
ID.4
Item
initial diagnosis of acute promyelocytic leukemia as defined by french-american-british criteria (bennett 1976)
boolean
C0023487 (UMLS CUI [1])
ID.5
Item
patient in blast crisis stage of chronic myeloid leukemia
boolean
C0919644 (UMLS CUI [1])
ID.6
Item
received high-dose cytarabine (total cumulative dose of >6g/m sq)in last 6 months
boolean
C0010711 (UMLS CUI [1])
ID.7
Item
interval of <6 months between first onset of last complete remission and current relapse
boolean
C0677874 (UMLS CUI [1,1])
C0035020 (UMLS CUI [1,2])
C0035020 (UMLS CUI [1,2])
ID.8
Item
those with primary refractory leukemia who have received more than three previous induction cycles
boolean
C0857127 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,2])
ID.9
Item
relapsed patients who have received more than three previous treatment regimens
boolean
C0392920 (UMLS CUI [1])